National Guideline Clearinghouse | Bosutinib for previously treated chronic myeloid leukaemia.

full-text ►

National Guideline Clearinghouse | Bosutinib for previously treated chronic myeloid leukaemia.



National Institute for Health and Care Excellence (NICE)

March 24, 2014

Guideline Title

Bosutinib for previously treated chronic myeloid leukaemia.

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Bosutinib for previously treated chronic myeloid leukaemia. London (UK): National Institute for Health and Care Excellence (NICE); 2013 Nov. 67 p. (Technology appraisal guidance; no. 299).

Guideline Status

This is the current release of the guideline.